Harman Patil (Editor)

Molecular Medicine Partnership Unit

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Molecular Medicine Partnership Unit

The Molecular Medicine Partnership Unit (MMPU) is an alliance between the European Molecular Biology Laboratory (EMBL) and the Medical Faculty of the University of Heidelberg. Its primary aim is to uncover the molecular basis of disease and to speed the transformation of biomedical discoveries into personalized medicine strategies.

Contents

Founded in 2002, the MMPU currently comprises nine international research teams. The MMPU is co-directed by Prof. Andreas Kulozik from the Angelika-Lautenschläger Hospital for Children and Adolescents at the University of Heidelberg and by Prof. Matthias Hentze from EMBL, and is housed in the Otto-Meyerhof-Research Center on the Medical Campus of the University of Heidelberg, Germany.

Research themes

Research themes place emphasis on common diseases, particularly blood disorders, cancer, chronic lung diseases (in particular cystic fibrosis), iron metabolism disorders, chronic pain, diseases associated with aging, and AIDS.

In 2017 more than 120 scientists from across the world work on these nine research themes:

  • ‘Diseases of mRNA metabolism’, headed by Andreas Kulozik and Matthias Hentze
  • ‘Cystic fibrosis/Chronic airway disease’, headed by Marcus Mall and Carsten Schultz
  • ‘Pathogenesis of colorectal cancer and development of novel approaches for early detection, diagnosis and prevention’, headed by Magnus von Knebel Doeberitz and Peer Bork
  • ‘Iron homeostasis in health and disease’, headed by Martina Muckenthaler and Matthias Hentze
  • ‘Early warning signals of aging in human stem cells’ headed by Anthony D. Ho and Anne-Claude Gavin.
  • ‘Interfering with assembly and maturation of infectious HIV-1’ headed by Hans-Georg Kräusslich and John Briggs.
  • ‘Molecular mediators of chronic pain’ headed by Rohini Kuner, Paul Heppenstall and Jan Siemens.
  • ‘Molecular Pediatric Oncology’ headed by Andreas Kulozik and Jan Korbel.
  • ‘Systems Medicine of Cancer Drugs’ headed by Sascha Dietrich and Wolfgang Huber.
  • Selected recent publications

  • Hauer, C.; Sieber, J.; Schwarzl, T.; et al. (2016). "Exon Junction Complexes Show a Distributional Bias toward Alternatively Spliced mRNAs and against mRNAs Coding for Ribosomal Proteins". Cell Rep. 16 (6): 1588–603. doi:10.1016/j.celrep.2016.06.096. PMC 4978704. PMID 27475226. 
  • Kloor, M.; von Knebel Doeberitz, M. (2016). "The Immune Biology of Microsatellite-Unstable Cancer". Trends in Cancer. 2 (3): 121–133. doi:10.1016/j.trecan.2016.02.004. 
  • Kunz, JB.; Rausch, T.; Bandapalli, OR.; et al. (2015). "Pediatric T-lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation". Haematologica. 100 (11): 1442–50. doi:10.3324/haematol.2015.129692. PMC 4825305. PMID 26294725. 
  • Schur, FK; Obr, M; Hagen, WJ; et al. (2016). "An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation". Science. 353 (6298): 506–8. doi:10.1126/science.aaf9620. PMID 27417497. 
  • Schur, FK; Hagen, WJ; Rumlová, M; et al. (2015). "Structure of the immature HIV-1 capsid in intact virus particles at 8.8 Å resolution". Nature. 517 (7535): 505–8. doi:10.1038/nature13838. PMID 25363765. 
  • Guida, C; Altamura, S; Klein, FA; et al. (2015). "A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia". Blood. 125 (14): 2265–75. doi:10.1182/blood-2014-08-595256. PMC 4383800. PMID 25662334. 
  • Selvaraj, D; Gangadharan, V; Michalski, CW; et al. (2015). "A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain". Cancer Cell. 27 (6): 780–96. doi:10.1016/j.ccell.2015.04.017. PMC 4469373. PMID 26058077. 
  • Hanack, C; Moroni, M; Lima, WC; et al. (2015). "GABA blocks pathological but not acute TRPV1 pain signals". Cell. 160 (4): 759–70. doi:10.1016/j.cell.2015.01.022. PMID 25679765. 
  • Bandapalli, OR.; Schuessele, S.; Kunz, JB.; et al. (2014). "The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse". Haematologica. 99 (10): e188–92. doi:10.3324/haematol.2014.104992. PMID 24972766. 
  • Bhuvanagiri, M.; Lewis, J.; Putzker, K.; et al. (2014). "5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion". EMBO Mol Med. 6 (12): 1593–609. doi:10.15252/emmm.201404461. PMC 4287977. PMID 25319547. 
  • Zeller, G.; Tap, J.; Voigt, AY.; et al. (2014). "Potential of fecal microbiota for early-stage detection of colorectal cancer". Mol Syst Biol. 10 (766). doi:10.15252/msb.20145645. PMC 4299606. PMID 25432777. 
  • Simonetti, M; Agarwal, N; Stösser, S; et al. (2014). "Wnt-Fzd signaling sensitizes peripheral sensory neurons via distinct noncanonical pathways". Neuron. 83 (1): 104–21. doi:10.1016/j.neuron.2014.05.037. PMID 24991956. 
  • Altamura, S; Kessler, R; Gröne, N; et al. (2014). "Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload". Cell Metab. 20 (2): 359–67. doi:10.1016/j.cmet.2014.07.007. PMID 25100063. 
  • Trojanek, JB; Cobos-Correa, A; Diemer, S; et al. (2014). "Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema". Am J Respir Cell Mol Biol. 51 (5): 709–20. doi:10.1165/rcmb.2013-0407OC. PMID 24828142. 
  • Gehrig, S; Duerr, J; Weitnauer, M; et al. (2014). "Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease". Am J Respir Crit Care Med. 189 (9): 1082–92. doi:10.1164/rccm.201311-1932OC. PMID 24678594. 
  • References

    Molecular Medicine Partnership Unit Wikipedia